CH647771A5 - Sulfoniumderivate. - Google Patents

Sulfoniumderivate. Download PDF

Info

Publication number
CH647771A5
CH647771A5 CH911/81A CH91181A CH647771A5 CH 647771 A5 CH647771 A5 CH 647771A5 CH 911/81 A CH911/81 A CH 911/81A CH 91181 A CH91181 A CH 91181A CH 647771 A5 CH647771 A5 CH 647771A5
Authority
CH
Switzerland
Prior art keywords
tetrahydro
furanyl
pyranyl
sulfide
formula
Prior art date
Application number
CH911/81A
Other languages
German (de)
English (en)
Inventor
Akihide Koda
Mikio Hori
Mitsugi Yasumoto
Ichiro Yamawaki
Yuji Yamada
Katsuo Takikawa
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP1838580A external-priority patent/JPS56123977A/ja
Priority claimed from JP850081A external-priority patent/JPS57122074A/ja
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of CH647771A5 publication Critical patent/CH647771A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Photolithography (AREA)
  • Plural Heterocyclic Compounds (AREA)
CH911/81A 1980-02-15 1981-02-11 Sulfoniumderivate. CH647771A5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1838580A JPS56123977A (en) 1980-02-15 1980-02-15 Sulfonium compound and its preparation
JP850081A JPS57122074A (en) 1981-01-21 1981-01-21 Sulfonium compound and its preparation

Publications (1)

Publication Number Publication Date
CH647771A5 true CH647771A5 (de) 1985-02-15

Family

ID=26343021

Family Applications (1)

Application Number Title Priority Date Filing Date
CH911/81A CH647771A5 (de) 1980-02-15 1981-02-11 Sulfoniumderivate.

Country Status (10)

Country Link
US (1) US4581372A (https=)
AU (1) AU522849B2 (https=)
CA (1) CA1169080A (https=)
CH (1) CH647771A5 (https=)
DE (1) DE3105303C2 (https=)
ES (1) ES500077A0 (https=)
FR (1) FR2476084A1 (https=)
GB (1) GB2070597B (https=)
IT (1) IT1172224B (https=)
NL (1) NL8100753A (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556737A (en) * 1983-03-11 1985-12-03 Taiho Pharmaceutical Company Limited Sulfonium compounds, processes for preparing the compounds and pharmacological composiitons containing the same
JPH0621072B2 (ja) * 1986-11-12 1994-03-23 呉羽化学工業株式会社 エストラジオ−ル誘導体よりなる免疫調節剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2562042A (en) * 1949-09-19 1951-07-24 American Home Foods Inc Tetrahydropyran-sulfide compounds
US3455956A (en) * 1965-02-24 1969-07-15 Takeda Chemical Industries Ltd Dialkyl-sulfoxides and dialkyl-sulfones
DE2332709A1 (de) * 1972-06-30 1974-01-10 Ciba Geigy Ag Verfahren zur herstellung von sulfoniumsalzen
IT1045036B (it) * 1975-02-19 1980-04-21 Zambon Spa Derivato del dimercaptoetil etere

Also Published As

Publication number Publication date
GB2070597A (en) 1981-09-09
US4581372A (en) 1986-04-08
AU6723481A (en) 1981-08-20
ES8201568A1 (es) 1982-01-01
DE3105303A1 (de) 1981-12-17
CA1169080A (en) 1984-06-12
NL8100753A (nl) 1981-09-16
GB2070597B (en) 1983-07-27
FR2476084A1 (fr) 1981-08-21
ES500077A0 (es) 1982-01-01
IT8167206A0 (it) 1981-02-13
DE3105303C2 (de) 1985-01-03
IT1172224B (it) 1987-06-18
AU522849B2 (en) 1982-07-01
FR2476084B1 (https=) 1983-07-08

Similar Documents

Publication Publication Date Title
DE3852288T2 (de) K-252-Derivate mit Antitumorwirkung und diese enthaltende Arzneimittel.
CH648037A5 (de) Imidazo-rifamycin-derivate mit antibakterieller wirksamkeit.
EP0242851A1 (de) N-(2'-Aminophenyl)-benzamid-Derivate, Verfahren zu deren Herstellung und deren Verwendung bei der Bekämpfung neoplastischer Erkrankungen
EP0189370A2 (de) Spiro-dioxolane, -dithiolane und -oxothiolane
WO1985000171A1 (fr) Spiroxuccinimides, leur fabrication et leur utilisation
EP0416401A2 (de) Verwendung von Phospholipid-Derivaten als antivirale Arzneimittel und neue Phospholipide
DE69131753T2 (de) Antibakterielle penem-esterderivate
DE68924722T2 (de) Substituiertes Benzoxazinorifamycinderivat, Verfahren zur Herstellung und dieses Derivat enthaltende Bakterizidmittel.
DE2641388C3 (de) 3',4'-Didesoxykanamycin B-N-methansulfonsäuren und deren Alkalimetallsalze sowie diese Verbindungen enthaltende pharmazeutische Präparate
EP0201094A2 (de) Neue Derivate von Thieno[2,3-d]-imidazolen und Verfahren zu ihrer Herstellung
DE3730748A1 (de) Neue polyoxygenierte labdanderivate, ein verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE2900118C2 (https=)
DE3308196C2 (https=)
EP0665228A1 (de) Neue 3-Phenylsulfonyl-3,7-diazabicyclo(3,3,1)nonan-Verbindungen enthaltende Arzneimittel
CH647771A5 (de) Sulfoniumderivate.
DE2733867B2 (de) Oleandomycinderivate und diese Verbindungen enthaltende antibakterielle Mittel
DE3132475C2 (https=)
DE2716172C2 (de) Bis(6-[(hexahydro-1H-azepin-1-yl)-methylenamino]-penicillanoyloxy)-methan, seine Herstellung und dieses enthaltendes Arzneimittel
EP0313935A2 (de) Enolether von 6-Chlor-4-hydroxy-2-methyl-N-(2-pyridyl)-2H-thieno(2,3-e)-1,2-thiazin-3-carbonsäureamid-1,1-dioxid, ein Verfahren zu ihrer Herstellung sowie ihre Verwendung
DE1620747C3 (de) Carbothiamin sowie dessen nichttoxische organische oder anorganische Säureadditionssalze sowie Verfahren zur Herstellung dieser Verbindungen
EP0328913A2 (de) Neue basisch substituierte 5-Halogen-Thienoisothiazol-3(2H)-on-1,1-dioxide, ein Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
DE3142401A1 (de) Aprosamin-derivate und diese verbindungen enthaltende arzneimittel
CH620208A5 (en) Process for the preparation of anticarcinogenic dianhydrohexitide-acyl derivatives
DE2900119C2 (de) 4''-Desoxy-4''-carbamat- und -dithiocarbamat-Derivate des 11-Acetyl-oleandomycins und deren Salze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0139859A2 (de) 1,4-Dihydropyridine, Verfahren zu ihrer Herstellung sowie ihre Verwendung in Arzneimitteln

Legal Events

Date Code Title Description
PL Patent ceased